Skip to content

Efficacy of matico (Buddleja globosa H.) on healing wounds and ulcers

Efficacy of matico (Buddleja globosa H.) on healing wounds and ulcers: a randomized, comparative, open-label study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN38989659
Enrollment
182
Registered
2014-03-26
Start date
2013-08-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and ulcers healing Skin and Connective Tissue Diseases Wounds and ulcers healing

Interventions

Visit 1 (week 1): 1. Inclusion/exclusion criteria flowchart, informed consent. 2. Baseline medical history, current medical status, physical examination. Participant randomly allocated to receive conv

Sponsors

National Commission for Scientific and Technological Research (CONICYT) (Chile)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women aged 18 to 75 years old 2. Type 1 or 2 wounds and ulcers 3. Body mass index between 20 and 35

Exclusion criteria

Exclusion criteria: 1. Either allergy to matico shrub (Buddleja globosa H.) or to any constituents of matico extract phytomedicine 2. Diagnostic of allergic/irritative dermatitis 3. Any vascular disease or varicose ulcer (including diabetic foot) 4. Skin neoplasia 5. Wounds/ulcers caused by radiation, or cytostatic/steroid drugs

Design outcomes

Primary

MeasureTime frame
1. Efficacy to heal type 1 or 2 wounds and ulcers 2. Time to heal type 1 or 2 wounds and ulcers 3. Security and adverse reactions 4. Medication compliance 5. Treatment cost for health system/patient Timepoints for all primary outcomes will be measured at baseline, and weekly from week 1 to 6.

Secondary

MeasureTime frame
1. Efficacy - ten parameters wil be used to evaluate healing efficacy; each parameter will be scored from 1 to 4 points, as is shown below: 1.1. Wound/ulcer visual aspect: 1.1.1. Eritematosus, one point 1.1.2. Redish, two points 1.1.3. Yellowish/pale, three points 1.1.4. Necrotic, four points 1.2. Wound/ulcer longer diameter (measured with a standard sterile plastic flexible ruler): 1.2.1. 0.0 to 1.0 cm, one point 1.2.2. 1.1 to 3.0 cm, two points 1.2.3. 3.1 to 6.0 cm, three points 1.2.4 6.1 cm or bigger, four points 1.3. Wound/ulcer depth (measured with a standard sterile plastic flexible ruler): 1.3.1. 0.0 cm, one point 1.3.2. 0.1 to 1.0 cm, two points 1.3.3. 1.1 to 3.0 cm, three points 1.3.4. 3.1 cm or bigger, four points 1.4. Wound/ulcer exudate quantity: 1.4.1. No, one point 1.4.2. Scarce, two points 1.4.3. Mild, three points 1.4.4. Plentiful, four points 1.5. Wound/ulcer exudate quality: 1.5.1. No, one point 1.5.2. Opaque, two points 1.5.3 Turbid, three points 1.5.4. Purulent, four points 1.6. Wound/ulcer necrotic tissue: 1.6.1. No, one point 1.6.2. Less than 25%, two points 1.6.3. 25% to 50%, three points 1.6.4. More than 50%, four points 1.7. Wound/ulcer granulatory tissue: 1.7.1. 100% to 75%, one point 1.7.2. 75% to 50%, two points 1.7.3. 50% to 25%, three points 1.7.4. 25% or less, four points 1.8. Wound/ulcer oedema: 1.8.1. No, one point 1.8.2. +, two points 1.8.3. ++, three points 1.8.4. +++, four points 1.9. Wound/ulcer pain: 1.9.1. 0 to 1, one point 1.9.2. 2 to 3, two points 1.9.3. 4 to 6, three points 1.9.4. 7 to 10, four points 1.10. Wound/ulcer surrounding skin parameters: 1.10.1. Normal, one point 1.10.2. Desquamated, two points 1.10.3. Eritematosus, three points 1.10.4. Macerated, four points Total score qualify type of wound/ulcer: 10 ? 15 points, type-1 16 ? 21 points, type-2 22 ? 27 points, type-3 28 ? 40 points, type-4 2. Time to heal: 2.1. Number of days to get healthy tissue 3. Security and adverse reaction: 3.1. Qualitative description 3.

Countries

Chile

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026